dr. sundar jagannath on three-drug regimen for newly diagnosed multiple myeloma
Published 8 years ago • 625 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
1:19
dr. sundar jagannath on significant studies in multiple myeloma
-
2:17
dr. sundar jagannath discusses the approval of lenalidomide in multiple myeloma
-
6:01
treating newly diagnosed multiple myeloma
-
1:54
dr. jagannath on next-generation approaches in multiple myeloma
-
1:21
dr. jagannath on potential of immunotherapy in multiple myeloma
-
3:11
top myeloma specialist: multiple myeloma survival rate improving! | the patient story
-
14:55
multiple myeloma cure in 2023 - dm(aiims) - cancer symptoms, stages, survival, treatment in hindi
-
31:15
multiple myeloma in 2023: what patients & caregivers need to know now! | the patient story
-
1:38
dr.jagannath on role for two-drug combinations, carfilzomib triplet in multiple myeloma
-
1:24
dr. jagannath on immunotherapy in multiple myeloma
-
1:40
dr. jagannath on treatment advances in transplant-ineligible patients with myeloma
-
1:24
dr. jagannath on the importance of biology in multiple myeloma
-
2:57
sundar jagannath, md, on what we should know when sequencing agents in treating multiple myeloma
-
1:26
dr. jagannath on sequencing therapies for patients with multiple myeloma
-
2:04
dr. jagannath on car t-cell therapy for multiple myeloma
-
1:54
dr. jagannath on the safety profile of selinexor in multiple myeloma
-
6:03
multiple myeloma regimens
-
2:30
dr. jagannath on targeted therapies and stem cell transplantation in multiple myeloma
-
3:17
dr. jagannath discusses advances in the management of relapsed multiple myeloma
-
2:12
dr. jagannath on mechanism of action of selinexor in myeloma
-
12:08
connect® mm: treatment patterns and holistic burden in triple-class refractory multiple myeloma
-
9:51
treatment of elderly patients with multiple myeloma